ANCA相关性血管炎肺受累研究现状(5)
[30]戴启春，胡粟，刘运练，等.显微镜下多血管炎肺损害的CT表现[J].临床放射学杂志，2013，32(11)：1576-1579.
[31]WangChrong-Reen，Tsai Yi-Shan，Tsai Hung-Wen.Acute Myocarditis in Patients with Antineutrophil Cytoplasmic Antibody-positive Microscopic Polyangiitis and Receiving Rituximab Therapy[J].The Journal of rheumatology，2019(12)：1645-1646.
[32]Shi L.Anti-neutrophil cytoplasmic antibody-associated vasculitis：prevalence，treatment，and outcomes[J].Rheumatology International，2017，37(11)：1779-1788.
[33]牟茂婷，楊爽，彭兰驭，等.抗中性粒细胞浆抗体相关性血管炎治疗研究进展[J].临床合理用药杂志，2019，12(10)：176-177.
[34]McBrien CN，Menzies-Gow A.Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis[J].Drugs Today (Barc)，2018，54(2)：93-101.
[35]Wechsler ME，Akuthota P，Jayne D，et al.Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis[J].New England Journal of Medicine，2017，376(20)：1921-1932.
[36]Holle JU，Dubrau C，Herlyn K，et al.Rituximab for refractory granulomatosis with polyangiitis(Wegener＼"s granulomatosis)：comparison of efficacy in granulomatous versus vasculitic manifestations[J].Annals of the Rheumatic Diseases，2012，71(3)：327-333.
[37]Nathan SD，Albera C，Bradford WZ，et al.Effect of pirfenidone on mortality： pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis[J].The Lancet Respiratory Medicine，2016，5(1)：33-41.
收稿日期：2019-12-07;修回日期：2019-12-23
编辑/王朵梅, 百拇医药(肖应梅 江涛)
[31]WangChrong-Reen，Tsai Yi-Shan，Tsai Hung-Wen.Acute Myocarditis in Patients with Antineutrophil Cytoplasmic Antibody-positive Microscopic Polyangiitis and Receiving Rituximab Therapy[J].The Journal of rheumatology，2019(12)：1645-1646.
[32]Shi L.Anti-neutrophil cytoplasmic antibody-associated vasculitis：prevalence，treatment，and outcomes[J].Rheumatology International，2017，37(11)：1779-1788.
[33]牟茂婷，楊爽，彭兰驭，等.抗中性粒细胞浆抗体相关性血管炎治疗研究进展[J].临床合理用药杂志，2019，12(10)：176-177.
[34]McBrien CN，Menzies-Gow A.Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis[J].Drugs Today (Barc)，2018，54(2)：93-101.
[35]Wechsler ME，Akuthota P，Jayne D，et al.Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis[J].New England Journal of Medicine，2017，376(20)：1921-1932.
[36]Holle JU，Dubrau C，Herlyn K，et al.Rituximab for refractory granulomatosis with polyangiitis(Wegener＼"s granulomatosis)：comparison of efficacy in granulomatous versus vasculitic manifestations[J].Annals of the Rheumatic Diseases，2012，71(3)：327-333.
[37]Nathan SD，Albera C，Bradford WZ，et al.Effect of pirfenidone on mortality： pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis[J].The Lancet Respiratory Medicine，2016，5(1)：33-41.
收稿日期：2019-12-07;修回日期：2019-12-23
编辑/王朵梅, 百拇医药(肖应梅 江涛)